Zhao J - Search Results

1

Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer.

Wang M, Zhao J, Su YJ, Zhao XL, Wang CL. Wang M, et al. Among authors: zhao j, zhao xl. Oncol Lett. 2012 Dec;4(6):1349-1353. doi: 10.3892/ol.2012.892. Epub 2012 Sep 3. Oncol Lett. 2012. PMID: 23226806 Free PMC article.

2

Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer.

Wang M, Zhao J, Zhang LM, Li H, Yu JP, Ren XB, Wang CL. Wang M, et al. Among authors: zhao j. J Cancer Res Clin Oncol. 2012 Dec;138(12):2069-77. doi: 10.1007/s00432-012-1291-2. Epub 2012 Jul 22. J Cancer Res Clin Oncol. 2012. PMID: 22821179

3

Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis?

Wang M, Zhao J, Pan Y, Su YJ, You J, Zhao XL, Wang CL. Wang M, et al. Among authors: zhao j, zhao xl. World J Surg. 2009 Mar;33(3):497-504. doi: 10.1007/s00268-008-9859-3. World J Surg. 2009. PMID: 19115028

4

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women.

Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, Fu L. Zhao J, et al. J Surg Oncol. 2009 Aug 1;100(2):89-94. doi: 10.1002/jso.21307. J Surg Oncol. 2009. PMID: 19544363

5

Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer.

Wu N, Zhang J, Zhao J, Mu K, Zhang J, Jin Z, Yu J, Liu J. Wu N, et al. Among authors: zhao j. Oncol Lett. 2018 Oct;16(4):4984-4996. doi: 10.3892/ol.2018.9290. Epub 2018 Aug 10. Oncol Lett. 2018. PMID: 30250564 Free PMC article. Review.

6

Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective Study.

Nie C, He Y, Lv H, Gao M, Gao X, Chen B, Xu W, Wang J, Liu Y, Zhao J, Chen X. Nie C, et al. Among authors: zhao j. Front Oncol. 2022 Jul 4;12:885350. doi: 10.3389/fonc.2022.885350. eCollection 2022. Front Oncol. 2022. PMID: 35860585 Free PMC article.

7

Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells.

Li Y, Dong S, Tamaskar A, Wang H, Zhao J, Ma H, Zhao Y. Li Y, et al. Among authors: zhao j, zhao y. Oncol Res. 2020 Dec 10;28(5):497-507. doi: 10.3727/096504020X15929939001042. Epub 2020 Jun 24. Oncol Res. 2020. PMID: 32580819 Free PMC article.

8

Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?

Niu HF, Wei LJ, Yu JP, Lian Z, Zhao J, Wu ZZ, Liu JT. Niu HF, et al. Among authors: zhao j. Cancer Biol Med. 2016 Mar;13(1):142-9. doi: 10.28092/j.issn.2095-3941.2015.0093. Cancer Biol Med. 2016. PMID: 27144069 Free PMC article.

9

Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study.

Nie C, Lv H, Chen B, Xu W, Wang J, Liu Y, Wang S, Zhao J, He Y, Chen X. Nie C, et al. Among authors: zhao j. Front Oncol. 2022 Sep 26;12:917353. doi: 10.3389/fonc.2022.917353. eCollection 2022. Front Oncol. 2022. PMID: 36226061 Free PMC article.

10

Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.

Zhuo X, Guo H, Ma J, Lai J, Liu L, Yin K, Zhao J, Wang J, Jiang F, Xu W, Yuan X, Lin X, Fu G. Zhuo X, et al. Among authors: zhao j. J Cancer Res Clin Oncol. 2023 May;149(5):2029-2039. doi: 10.1007/s00432-022-04196-7. Epub 2022 Jul 13. J Cancer Res Clin Oncol. 2023. PMID: 35829744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,163 results

Search Page

Filters